The Brief
Aurum Biosciences is a clinical-stage company based at the Queen Elizabeth University Hospital campus in Glasgow. It is developing ABL-101, an oxygen carrier small enough to reach brain tissue that blood can't, as a treatment and diagnostic for acute stroke. Aurum needed a website that would make that science easy to follow for investors, clinicians and partners, and show a company ready for its Phase 2 trials.
What We Built
• A clean, confident design led by one clear message: "Delivering oxygen where blood cannot."
• An Our science page that explains how ABL-101 works in plain language, for readers who aren't specialists.
• A Pipeline page setting out the Phase 2 trials in stroke and carotid imaging.
• Pages for the team, investors and news, with backers such as Wellcome Trust and Scottish Enterprise shown on the home page.
• Headline figures and clear routes to get in touch, for investors and partners.
The Result
Aurum has a website that matches the ambition of its science. Investors and partners can understand the opportunity in a few minutes, and the team can add news as the trials progress.
